Authors:
Cao, BP
Peres, T
Cross, RJ
Saunders, M
Lifshitz, C
Citation: Bp. Cao et al., Do nitrogen-atom-containing endohedral fullerenes undergo the shrink-wrap mechanism?, J PHYS CH A, 105(11), 2001, pp. 2142-2146
Authors:
Smith, DG
Buffet, M
Fenwick, AE
Haigh, D
Ife, RJ
Saunders, M
Slingsby, BP
Stacey, R
Ward, RW
Citation: Dg. Smith et al., 3-anilino-4-arylmaleimides: Potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3), BIOORG MED, 11(5), 2001, pp. 635-639
Citation: F. Macbeth et M. Saunders, Synchronous chemoradiation for squamous carcinomas - This treatment is notgold standard for lung cancer, BR MED J, 323(7310), 2001, pp. 453-453
Citation: M. Saunders, The friends of friendless churches: Lightcliffe Old Church (St Matthew), Halifax, West Yorkshire, T ANC MONUM, 45, 2001, pp. 109-118
Authors:
Chandrasekhar, J
Saunders, M
Jorgensen, WL
Citation: J. Chandrasekhar et al., Efficient exploration of conformational space using the stochastic search method: Application to beta-peptide oligomers, J COMPUT CH, 22(14), 2001, pp. 1646-1654
Authors:
Millard, RK
Saunders, M
Palmer, AM
Preece, AW
Citation: Rk. Millard et al., Approximate distribution of dose among foetal organs for radioiodine uptake via placenta transfer, PHYS MED BI, 46(11), 2001, pp. 2773-2783
Authors:
Fujiwara, K
Komatsu, K
Wang, GW
Tanaka, T
Hirata, K
Yamamoto, K
Saunders, M
Citation: K. Fujiwara et al., Derivatization of fullerene dimer C-120 by the Bingel reaction and a He-3 NMR study of He-3@C-120 monoadducts, J AM CHEM S, 123(43), 2001, pp. 10715-10720
Authors:
Nossal, J
Saini, RK
Sadana, AK
Bettinger, HF
Alemany, LB
Scuseria, GE
Billups, WE
Saunders, M
Khong, A
Weisemann, R
Citation: J. Nossal et al., Formation, isolation, spectroscopic properties, and calculated properties of some isomers of C60H36, J AM CHEM S, 123(35), 2001, pp. 8482-8495
Citation: Gw. Wang et al., Reversible Dials-Alder addition to fullerenes: A study of equilibria usingHe-3 NMR spectroscopy, J AM CHEM S, 123(2), 2001, pp. 256-259
Authors:
Braybrooke, JP
O'Byrne, KJ
Propper, DJ
Blann, A
Saunders, M
Dobbs, N
Han, C
Woodhull, J
Mitchell, K
Crew, J
Smith, K
Stephens, R
Ganesan, TS
Talbot, DC
Harris, AL
Citation: Jp. Braybrooke et al., A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis, CLIN CANC R, 6(12), 2000, pp. 4697-4704